The Artificial Kidney Prize is a competition to accelerate the development of artificial kidneys toward human clinical trials. Phases 1 and 2 will award up to $10 million in prizes.
The Artificial Kidney Prize builds on past KidneyX competitions but is distinct in its goal: to accelerate the development of continuous kidney replacement therapies that provide transformational treatment options beyond current dialysis methods. Artificial kidneys may be wearable, implantable, bioengineered, developed as a xenotransplant or chimera organ, or other approaches not yet conceived.
Enter Phase 1 by March 24
Phase 1 seeks component or integrated prototype solutions that enable and advance the functionality, effectiveness, and/or reliability of artificial kidneys. Phase 1 submissions are due by 4:59 p.m. ET on March 24, 2021.
Looking ahead to Phase 2
Phase 2 of the Artificial Kidney Prize will be open to eligible entrants from Phase 1, as well as new eligible entrants who did not enter the first phase. The second phase will focus on initial integration of prototype solutions into an artificial kidney, or advancement of already integrated prototype solutions. Phase 2 is expected to launch in fall 2021.
At the discretion of HHS and ASN, additional competition phases may follow Phase 2 to further accelerate development of artificial kidneys. KidneyX hopes to secure a total of $200 million to support all phases.
Learn more about the Artificial Kidney Prize.